Àîºê°å²ÊÂç³Ø¥í¥´
HOME > ¶µ¼¼¾Ò²ð > ÆýÁ£¹Ã¾õÁ£³°²Ê³Ø¶µ¼¼
°ìÈ̶µÍÜ
´ðÁÃ°å³Ø
±þÍÑ°å³Ø
Î×¾²°å³Ø
¸¦µæ¥»¥ó¥¿¡¼

ÆýÁ£¹Ã¾õÁ£³°²Ê³Ø¶µ¼¼




¶µ¼ø±àÈø Çî»Ê
½Ú¶µ¼ø¹ÈÎÓ ½ß°ì
¹Ö»ÕÅÄÃæ ¹î¹À
¹Ö»ÕÃæÅç °ìµ£
¹Ö»ÕÄÇÌÚ ¼¢Íº
¹Ö»Õ»³ËÜ Íµ
Î×¾²½õ¶µ¿åÆ£ ¾½»Ò
Î×¾²½õ¶µ´Ø ¿¿Íý
Î×¾²½õ¶µÆ£°æ À¶¹á
Î×¾²½õ¶µÂÀÅÄ Íµ²ð
Î×¾²½õ¶µã·Æ£ ÏÊ
Î×¾²½õ¶µ»³²¼ ůÀµ

¡¡ÆýÁ£¹Ã¾õÁ£³°²Ê¤ÎÆÈΩ¤·¤¿¶µ¼¼¤ò¤â¤ÄÂç³Ø¤Ï¶Ë¤á¤Æ¾¯¤Ê¤¯¡¢ËÜ³Ø¤ÎÆÃ¿§¤Î¤Ò¤È¤Ä¤Ç¤¢¤ë¡£ÆýÁ£¡¦¹Ã¾õÁ£¡ÊÉû¹Ã¾õÁ£¡Ë³°²Ê¤Ï¡¢¤½¤ÎÂоݤ¬­¡É½ºßÀ­Â¡´ï¡¢­¢¥Û¥ë¥â¥óµÚ¤Ó¤½¤ÎɸŪ´ï´±¤È¤¤¤¦ÆÃÀ­¤¬¤¢¤ê¡¢¤½¤Î¤¿¤á¡¢¿¨¿Ç¡¢¼«¸Ê¸¡¿Ç¡¢ÈþÍÆ¤Ê¤É¤¬½Å»ë¤µ¤ì¡¢¤µ¤é¤Ë¥Û¥ë¥â¥óµÚ¤Ó¥Û¥ë¥â¥óÎÅË¡¤ÎÀìÌçŪÃ챤òɬÍפȤ¹¤ëÅÀ¤¬¡¢Â¾¤Î°ìÈ̳°²Ê¤ÈÂ礭¤¯°Û¤Ê¤ë¡£¤³¤ì¤é¤ÎÆÃÀ­¤òƧ¤Þ¤¨¤Æ¡¢ÆýÁ£¡¦¹Ã¾õÁ£¡ÊÉû¹Ã¾õÁ£¡Ë³°²Ê°å¤È¤·¤Æ¤Î¿ÇÎŵ»½Ñ¤Ï¤â¤È¤è¤ê¡¢¹ñºÝŪ¤ËÄÌÍѤ¹¤ë¸¦µæ¤ò¹Ô¤¤¡¢ÆýÁ£¡¦¹Ã¾õÁ£¡ÊÉû¹Ã¾õÁ£¡Ë³°²Ê¤Î¥¹¥Ú¥·¥ã¥ê¥¹¥È¤È¤·¤ÆÆÈΩ¤Ç¤­¤ë°å»Õ¤Î°éÀ®¤òÌܻؤ·¤Æ¤¤¤ë¡£ÆüËÜ¤ÎÆýÁ£¹Ã¾õÁ£³°²Ê¤Î¿ÊÊâ¤Ë¤¤¤µ¤µ¤«¤Ç¤â´óÍ¿¤Ç¤­¤ì¤Ð¤È¹Í¤¨¤Æ¤¤¤ë¡£
¡¡¶µ°éÌ̤Ǥϡ¢³ØÀ¸¤ä¥ì¥¸¥Ç¥ó¥È¤ËÂФ·¤Æ¶¹¤¤ÆýÁ£¹Ã¾õÁ£³°²Ê¤ò¶µ¤¨¤ë¤Î¤Ç¤Ï¤Ê¤¯¡¢¹­¤¯³°²Ê³Ø¤¢¤ë¤¤¤Ï¼ðá硦ÆâʬÈç³ØÁ´ÂΤÎή¤ì¤«¤é¤ß¤¿ÆýÁ£¹Ã¾õÁ£³°²Ê³Ø¤Î´ðËܤò¥¹¥¿¥Ã¥Õ¤È¶¨ÎϤ·¤Æ¶µ¤¨¤ë¡£
¡¡Åö¶µ¼¼¤Ï¡¢ÆýÁ£¹Ã¾õÁ£³°²Ê¤Î¸¦µæ¡¦¿ÇÎŤˤª¤±¤ëÃæ¹ñ»Í¹ñÃ϶è¤ÎµòÅÀ¤È¤Ê¤Ã¤Æ¤ª¤ê¡¢Æý´â¡¢¹Ã¾õÁ£´â¡¢¥Ð¥»¥É¥¦É¡¢Éû¹Ã¾õÁ£µ¡Ç½Ð¶¿Ê¾É¤Ê¤É¤ÎË­É٤ʾÉÎ㤬¤¢¤ê¡¢ÆüËܤγزñ¤ò¥ê¡¼¥É¤¹¤ë½¼¼Â¤·¤¿¥¹¥¿¥Ã¥Õ¤¬¤½¤í¤Ã¤Æ¤¤¤ë¤Î¤Ç¡¢¶µ°éÌ̤ǤâÍ­Íø¤Ç¤¢¤ë¡£
¡¡2ǯ´Ö¤Îɬ½¤²½¸¦½¤¤ò´Þ¤á¹ç·×8ǯ´Ö¤Î³°²Ê¸¦½¤´ü´Ö¤òÀߤ±¤Æ¤¤¤ë¡£¤³¤Î´Ö¤Ë¾Ã²½´ïµÚ¤Ó¶»Éô¡¦¿´Â¡·ì´É³°²Ê¤Î´ðËܤò½¤ÆÀ¤¹¤ë¤È¤È¤â¤Ë¡¢ÆýÁ£¹Ã¾õÁ£³°²Ê¤Î¥¹¥Ú¥·¥ã¥ê¥¹¥È°éÀ®¤Î¸¦½¤¥×¥í¥°¥é¥à¤òÍѰդ·¤Æ¤¤¤ë¡£¤¹¤Ê¤ï¤Á2ǯ´Ö¤Îɬ½¤¸¦½¤¤Î¸å¤ËÅö²Ê¤Ë½ê°¤·¡¢¤µ¤é¤Ë2ǯ´Ö³°²Ê·Ï¡ÊÆýÁ£¹Ã¾õÁ£¡¢¾Ã²½´ï¡¢¶»Éô¿´Â¡·ì´É¡¢¾®»ù³°²Ê¡Ë¤ò¥í¡¼¥Æ¡¼¥·¥ç¥ó¤·¡¢³°²ÊÀìÌç°å¤ÈÆý´â³Ø²ñǧÄê°å¼èÆÀ¤òÌܻؤ¹¡£¤½¤Î¸åÅö²Ê¤Ç4ǯ´Ö¸¦½¤¤¹¤ì¤ÐÆýÁ£ÀìÌç°å¤Î»ñ³Ê¼èÆÀ¤¬¤Ç¤­¡¢¥¹¥Ú¥·¥ã¥ê¥¹¥È¤È¤·¤Æ¤ÎÆ»¤¬³«¤±¤ë¡£¶áǯ¡¢Æý´â´µ¼Ô¤ÎÁý²Ã¤Ëȼ¤¤¡¢ÆýÁ£³°²Ê°å¤Î¼ûÍפ¬µÞÁý¤·¤Æ¤¤¤ë¤Î¤Ç¤ä¤ê¤¬¤¤¤Î¤¢¤ëÎΰè¤Ç¤¢¤ë¡£¤Þ¤¿¡¢Âç³Ø±¡¤Ø¤Î¿Ê³Ø¤ÏÅö²Ê¤Ë½ê°¤·¤¿Ãʳ¬¤«¤é²Äǽ¤Ç¤¢¤ë¤¬¡¢Â´¸å4ǯ·Ð²á¤·¤¿¸å¤ËÆþ³Ø¤¹¤ë¤³¤È¤ò´«¤á¤¿¤¤¡£

¡û¼«¸Êɾ²Á¤ÈÈ¿¾Ê
¡¡³ØÀ¸¶µ°é¤Ë´Ø¤·¤Æ¤Ï¡¢3ǯÀ¸¡¢4ǯÀ¸¤Î¥Ö¥í¥Ã¥¯¹ÖµÁ¤Ï¼ç¤È¤·¤Æ¶µ¼ø¤¬¹Ô¤Ã¤Æ¤¤¤ë¤¬¡¢¶µºà¤Ï¥×¥ê¥ó¥È¤Î¤ß¤Ç¤Ê¤¯¡¢¤Ç¤­¤ë¤À¤±¥¹¥é¥¤¥É¤ò»ÈÍѤ·°õ¾Ý¤Å¤±¤ë¤è¤¦¤Ë¤·¤¿¡£5ǯÀ¸¤ÎÎ×¾²¼Â½¬¤Ï¡¢¥¹¥¿¥Ã¥ÕÁ´°÷¤¬¶¨ÎϤ·¤Æ¹Ô¤¨¤Æ¤ª¤ê¡¢¹Ö»Õ°Ê¾å¤Î¥¹¥¿¥Ã¥ÕÁ´°÷¤¬¡¢ÆýÁ£¡¢¹Ã¾õÁ£¡¦Éû¹Ã¾õÁ£¤òÃæ¿´¤Ëʬô¹ÖµÁ¤ò¹Ô¤¤¡¢ºÇ½ªÆü¤Ë¤ÏÁ´°÷¤¬¸ýƬ»îÌä¤ò¹Ô¤¤É¾²Á¡¦ºÎÅÀ¤·¤Æ¤¤¤ë¡£¤Þ¤¿¡¢¥«¥ó¥Õ¥¡¥ì¥ó¥¹»þ¤ËôÅö¾ÉÎã¤ÎȯɽµÚ¤Ó¼Áµ¿±þÅú¤Ï¤â¤Á¤í¤ó¤Î¤³¤È¡¢È¯É½¤ò¤Þ¤È¤á¤ë²ÝÄø¤Ç¥¹¥¿¥Ã¥Õ¤Ë¤è¤ë¤­¤áºÙ¤«¤Ê»ØÆ³¤ò¿´¤¬¤±¤Æ¤¤¤ë¡£¤µ¤é¤Ë¡¢Áí²ó¿Ç»þ¤Ë¤Ï¿¨¿Ç¤Ê¤É¤Î¼Âµ»»ØÆ³¤ò¹Ô¤Ã¤Æ¤ª¤ê¡¢³°Íè¼Â½¬¤â¼è¤êÆþ¤ì¤Æ¤¤¤ë¡£°ìÊý¡¢¥ì¥¸¥Ç¥ó¥È¤ËÂФ¹¤ë¶µ°é¤Ï¡¢¼ê½Ñ¤Ï¼ÂÎϤ˱þ¤¸¤Æ½Ñ¼Ô¤È¤·¤Æ·±Îý¤·¤Æ¤¤¤ë¡£¤Þ¤¿¡¢¸¦µæ²ñ¤ä³Ø²ñȯɽ¡¢ÏÀʸ¼¹É®¤â¤Ç¤­¤ë¤À¤±¹Ô¤¨¤ëµ¡²ñ¤òÍ¿¤¨¶µ°é¤·¤Æ¤¤¤ë¡£º£Ç¯¤âÅö²Ê¤Î¥·¥Ë¥¢¥ì¥¸¥Ç¥ó¥ÈÁ´°÷¤¬Á´¹ñ³Ø²ñ¤Çȯɽ¤·¤¿¡£

¡¡¼ç¤È¤·¤ÆÆý´â¡¢¹Ã¾õÁ£¡¦Éû¹Ã¾õÁ£¤Ë´Ø¤¹¤ëÎ×¾²ÅªµÚ¤Ó´ðÁÃŪ¸¦µæ¤ò¹Ô¤Ã¤Æ¤¤¤ë¡£
1.Æý´â
(1)Æý˼²¹Â¸¼ê½ÑµÚ¤ÓÈé²¼ÆýÁ£Á´Å¦¡Ü¥Æ¥£¥·¥å¥¨¥¯¥¹¥Ñ¥ó¥À¡¼ÁÞÆþ½Ñ
(2)¥¢¥¤¥½¥È¡¼¥×¡¦¿§ÁÇˡʻÍѤΥ»¥ó¥Á¥Í¥ë¥ê¥ó¥ÑÀáÀ¸¸¡¤ÎÎ×¾²±þÍÑ
(3)¥Ò¥ÈÆý´âºÙ˦³ô¤òÍѤ¤¤¿³Æ¼ï¹³´âÌôʪÎÅË¡¤Î´ðÁÃŪ¸¦µæ
(4)Æý´â¥ê¥¹¥¯°ø»Ò¤Î±Ö³ØÅª¸¦µæ
(5)¹üž°Ü¤Î¿ÇÃÇ¡¦¼£ÎÅ¡¦QOL¤ÎÎ×¾²Åª¸¦µæ
(6)¥Û¥ë¥â¥óÎÅË¡¤ª¤è¤Óʬ»ÒɸŪÎÅË¡¤Ë´Ø¤¹¤ë´ðÁÃŪ¡¦Î×¾²Åª¸¦µæ
(7)ºÆÈ¯Æý´â¤Î½¸³ØÅª¼£ÎÅ

2.¹Ã¾õÁ£¡¦Éû¹Ã¾õÁ£
(1)¹Ã¾õÁ£´â¡¢¥Ð¥»¥É¥¦É¡¢¾åÈé¾®Âε¡Ç½Ð¶¿Ê¾É¤Î¼ê½ÑÎÅË¡
(2)¹Ã¾õÁ£Ê¬²½´â¤Î¥Û¥ë¥â¥óÀ©¸æµÚ¤Óͽ¸å°ø»Ò¤Ë´Ø¤¹¤ë´ðÁÃŪ¸¦µæ
(3)Éû¹Ã¾õÁ£µ¡Ç½°Û¾ï¾É¤È¥«¥ë¥·¥¦¥àÂå¼Õ
(4)¹Ã¾õÁ£¡¢¾åÈé¾®ÂΤβèÁü¿ÇÃÇ
(5)¥Ò¥È¹Ã¾õÁ£´âºÙ˦³ô¤òÍѤ¤¤¿´ðÁÃŪ¸¦µæ

¡û¼«¸Êɾ²Á¤ÈÈ¿¾Ê
¡¡¤Û¤È¤ó¤É¤Î¥¹¥¿¥Ã¥Õ¤ÏÆýÁ£¡¢¹Ã¾õÁ£¤òÃæ¿´¤È¤¹¤ëÎ×¾²¸¦µæ¤òÀѶËŪ¤Ë¹Ô¤Ã¤Æ¤¤¤ë¤¬¡¢¾ÉÎ㤬µÞÁý¤·¤Æ¤¤¤ë¸½¾õ¤Î¿˻¤Ê¿ÇÎŤÎÃæ¤Ç¡¢¤³¤ì¤ò¹Ô¤¦¤³¤È¤ÏÍÆ°×¤Ç¤Ï¤Ê¤¤¡£³Ø²ñ³èư¤ÏÁ´¹ñŪ¤Ë¤âɾ²Á¤Ç¤­¤ë¥ì¥Ù¥ë¤Ç¤¢¤ë¤¬¡¢ÏÀʸ¶ÈÀӤϰìÉô¤Î¥¹¥¿¥Ã¥Õ¤ò½ü¤­ÉÔ½½Ê¬¤Ç¤¢¤ë¡£¸Ä¡¹¤Î»ÜÀߤθ¤é¤ì¤¿¾ÉÎã¤Ç¤ÎÎ×¾²¸¦µæ¤ÏÆÈÁÏÀ­¤Ë¸Â¤ê¤¬¤¢¤ë¤Î¤ÇÅö²Ê¤¬Ãæ¿´¤È¤Ê¤ê¡¢Ãæ¹ñ»Í¹ñÃ϶è¤Î¾»ÜÀߤȶ¦Æ±¤·¤¿Î×¾²¸¦µæ¤ò¼Â»Ü¤·¤Æ¤¤¤ë¤¬¡¢ÃÏÊý¥ì¥Ù¥ë¤ÎÎ×¾²¸¦µæ¤Ï¤Ê¤«¤Ê¤«¿Ê¤Þ¤Ê¤¤¤Î¤¬¼Â¾õ¤Ç¤¢¤ë¡£
¡¡¸ú²Ì¤Î¤¢¤¬¤ë³ØÀ¸¶µ°é¤ò¿´¤¬¤±¤¿¤¤¡£¤½¤Î¤¿¤á¤Ë¤Ï½àÈ÷¤Ë»þ´Ö¤ò¤«¤±¤Æ¾ðÇ®¤¢¤ë¹ÖµÁ¤ò¹Ô¤¦¤³¤È¡¢ÂÐÏ÷Á¼°¤Î¹ÖµÁ¤ò¼è¤êÆþ¤ì°õ¾Ý¤Å¤±¤ë¹©ÉפâɬÍפǤ¢¤ë¡£5ǯÀ¸¤ÎÎ×¾²¼Â½¬¤Ï¡¢°ú¤­Â³¤­¸½¾ì¤ÎÁ¯ÌÀ¤Ê°õ¾Ý¤«¤éÀ¸¤­¤¿Ã챤òÂÎÆÀ¤Ç¤­¤ë¤è¤¦¤ËÅØÎϤ·¤¿¤¤¡£¥ì¥¸¥Ç¥ó¥È¤Ë¤ÏÎ×¾²°å¤È¤·¤Æ¤Î·±Îý¤Î¤Û¤«¤Ë¸¦µæ¤ä³Ø²ñ³èư¤¬¾­Í輫ʬ¤Ç¤Ç¤­¤ë¤è¤¦¤Ë°ú³¤­¶µ°é¤¹¤ë¡£¤Þ¤¿¡¢´ðÁø¦µæ¤Ï¤â¤Á¤í¤ó¤Î¤³¤È¡¢¿·¤·¤¤¼£ÎÅË¡¤Ê¤É¤òÅö¶µ¼¼¤«¤éȯ¿®¤Ç¤­¤ë¤è¤¦ÅØÎϤ¹¤ë¤È¤È¤â¤Ë¡¢Á´¹ñ¥ì¥Ù¥ë¤ÎÎ×¾²¸¦µæ¤Ë¤âÀѶËŪ¤Ë²Ã¤ï¤ê¤¿¤¤¡£
  1. ±àÈøÇî»Ê¡§Æý˼²¹Â¸½Ñ¡¥¼ê½Ñ¡¡63¡§1439-1444¡¤2009
  2. ±àÈøÇî»Ê¡§ÆÃ½¸¡¡Æý´â¼£ÎŤκÇÁ°Àþ¡¡1 ¡¥Æý´â¥¬¥¤¥É¥é¥¤¥ó¡¥³°²Ê¡¡71¡§1142-1147¡¤2009
  3. ±àÈøÇî»Ê¡§Âè6¾Ï¡¡¥È¥Ô¥Ã¥¯¥¹¡¥¡ÖÆýÁ£³°²Ê¡×¤ÎɸÜÖ¡¥¤³¤ì¤«¤é¤ÎÆý´â¿ÇÎÅ2009-2010¡Ê´Æ½¤±àÈøÇî»Ê¡Ë¡¥Åìµþ¡¤¶â¸¶½ÐÈÇ¡¥2009¡¤pp124-126
  4. Kurebayashi J : Adjuvant therapy for premenopausal patients with early breast cancer. Curr Opin Obstet Gynecol 20 : 51-54, 2008
  5. Kurebayashi J, Ikeda M, Nakashima K, et al.: The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast 16 : S72-S77, 2007
  6. Kurebayashi J, Nomura T, Hirono M, et al.: Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells. Cancer Chemother Pharmacol 59 : 515-525, 2007
  7. Tanaka K, Ikeda M, Sonoo H, et al.: The relationship between Wilms' tumor 1(WT1) and paired box 8 (pax-8) protein expressions in papillary and anaplastic thyoid carcinomas. Kawasaki Med J 33 : 23-33, 2007
  8. ÃæÅç°ìµ£¡§½ÑÁ°ÌôʪÎÅË¡¤Î¸ú²ÌȽÄê¤Ë¤ª¤±¤ëͲ»ÇÈ¿ÇÃǤθ½¾õ¤ÈŸ˾¡¥Æý´â¤ÎÎ×¾²¡¡23¡§357-370, 2008
  9. ÃæÅç°ìµ£¡§ÆýÁ£¼À´µ¿ÇÃǤ˹׸¥¤¹¤ë¿·¤·¤¤Ä¶²»ÇÈ¿ÇÃÇ¥·¥¹¥Æ¥à¡¥±ÇÁü¾ðÊó¡¡Medical¡¡40¡§1107-1114¡¤1080-1083¡¤2008
  10. ÄÇÌÚ¼¢Íº¡¤±àÈøÇî»Ê¡§¡Ú½èÃ֤Ⱦ®¼ê½Ñ¤Î¥³¥Ä¤È¹çÊ»¾É¡Û½èÃÖ³ÆÏÀ¡¡µÞÀ­ÆýÁ£±ê¡¤ËýÀ­ÆýÁ£±ê¤Î½èÃÖ¡¥³°²Ê¡¡70¡§1328-1331¡¤2008

¤ªÌä¹ç¤» ¸Ä¿Í¾ðÊóÊݸîÊý¿Ë ¥µ¥¤¥È¥Ý¥ê¥·¡¼